Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:58 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2401–2424 of 7,489 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Control Clear all

Conditions: Lymphedema of Face, Secondary Lymphedema
Interventions: Complete Decongestive Therapy, Observation; Procedure · Other
Lead sponsor: Our Lady of the Lake Hospital; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Coagulation Delay
Interventions: phytonadione; Dietary Supplement
Lead sponsor: James A. Haley Veterans Administration Hospital; Federal
Eligibility: 18 Years and older
Enrollment: 370 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Colorectal Cancer Screening
Interventions: Best clinical practices plus culturally targeted print materials, Best clinical practices plus standard print materials, Best clinical practices alone; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 50 Years to 85 Years
Enrollment: 386 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Sexually Transmitted Diseases
Interventions: Synthetic Nitrile Condom (61mm), Control Latex Condom; Device
Lead sponsor: Karex Industries Sdn. Bhd.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 305 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Berkeley, California • Los Angeles, California

Conditions: Preeclampsia Severe, Preeclampsia Postpartum
Interventions: Magnesium Sulfate; Drug
Lead sponsor: Alexander Harrison; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: HNSCC
Interventions: Cesium-131, Pembrolizumab; Device · Drug
Lead sponsor: University of Cincinnati; Other
Eligibility: 19 Years to 90 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Cincinnati, Ohio • Philadelphia, Pennsylvania

Conditions: Anxiety
Interventions: Music, Control Group (no music); Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Non-Small Cell Lung Cancer
Interventions: JDQ443, docetaxel; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Renton, Washington

Conditions: Gastrointestinal Cancer, Head and Neck Cancer, Dihydropyrimidine Dehydrogenase Deficiency, UGT1A1 Gene Mutation, Breast Cancer
Interventions: Availability of clinical decision support based on pharmacogenomic results.; Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 860 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Colorectal Cancer
Interventions: Patient Navigation, Usual Care Control; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 45 Years to 915 Months
Enrollment: 527 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Health Literacy, Randomized Controlled Trial, Postpartum, Cesarean Delivery Affecting Newborn
Interventions: Visual Aid, Standard Instructions; Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Type 1 Diabetes Mellitus
Interventions: The 3Ms Intervention; Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: 10 Years to 15 Years
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 7
States / cities: Chicago, Illinois • Detroit, Michigan • Royal Oak, Michigan

Conditions: Grief, Bereavement, Cancer
Interventions: Meaning-Centered Grief Therapy, Supportive Psychotherapy, Enhanced Usual Care; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 415 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 5
States / cities: Stanford, California • Miami, Florida • New York, New York + 2 more

Conditions: Gastrointestinal Diseases
Interventions: EVICEL Fibrin Sealant; Biological
Lead sponsor: Ethicon, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 8
States / cities: Irvine, California • Jacksonville, Florida • Augusta, Georgia + 4 more

Conditions: End Stage Renal Disease, Renal Anemia, Chronic Kidney Diseases
Interventions: Anemia Controller; Other
Lead sponsor: Renal Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Foot Ulcer, Diabetic
Interventions: MatriStem, Cellular Dermal Replacement Tissue; Device
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 9
States / cities: Phoenix, Arizona • Castro Valley, California • Fresno, California + 5 more

Conditions: Type 1 Diabetes
Interventions: Dexcom G7 rtCGM, Capillary Blood glucose Testing (POC); Device · Diagnostic Test
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Birth Control, Contraception, Contraceptive Usage, Family Planning
Interventions: Additional Standardized Counseling; Other
Lead sponsor: Planned Parenthood of the St. Louis Region and Southwest Missouri; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 348 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Chronic Migraine, Behavioral Treatment, Biofeedback, Virtual Reality, Medication Overuse Headache
Interventions: Combined biofeedback-virtual reality device; Device
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Breast Cancer, Pain
Interventions: acupuncture therapy, sham acupuncture; Procedure
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older · Female only
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 47
States / cities: Antioch, California • Fremont, California • Los Angeles, California + 36 more

Conditions: Heart Failure
Interventions: iCardia4HF; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 40 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Esophageal Neoplasm, Esophageal Polyp, Endoscopic Submucosal Dissection, Bipolar Electocautery
Interventions: Endoscopic Submucosal Dissection, Bipolar electrocautery knife; Procedure · Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Allergic Fungal Rhinosinusitis
Interventions: Dupilumab, Placebo, Intranasal Corticosteroid Sprays (INCS); Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Atlanta, Georgia • Houston, Texas

Conditions: Heart Failure
Interventions: Biobeat Wrist Watch, Standard of Care; Device · Other
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 8
States / cities: New Haven, Connecticut • Stamford, Connecticut • Waterloo, Iowa + 5 more

Search by objective public record fields.

Complete Decongestive Therapy on Head and Neck Lymphedema

Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy

Improving Colorectal Cancer Screening for Diverse Hispanics in Urban Primary Care

Evaluation of Synthetic Nitrile Male Condom Compared to Standard Latex Male Condom

Biomarkers in Management of Post Partum Preeclampsia

Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC

Intraoperative Music Therapy in TAVR Patients

Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

Colonoscopy Outreach for Rural Communities Aim 2

Enhancing Postpartum Discharge Instructions

Effectiveness Trial of an E-Health Intervention To Support Diabetes Care in Minority Youth (3Ms)

Evaluation of Grief Therapy Approaches for Bereaved Parents

The EVICEL® Gastrointestinal Study

Assessment of an Anemia Model Predictive Controller for Anemia Management in Hemodialysis Patients

A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers

A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes

RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users

Biofeedback-VR for Treatment of Chronic Migraine

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

Patient-centered Mobile Health Intervention to Improve Self-care in Patients With Chronic Heart Failure

Monopolar and Bipolar in Esophageal ESD

Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)

Heart Failure Study to Evaluate Vital Signs and Overcome Low Use of Guideline-Directed Therapy by Remote Monitoring